Technicals

Shell (RDS.A) Q3 Earnings Miss, Cash Flow Soars to $12B

An Earnings Miss: Europe’s largest oil company Royal Dutch Shell plc RDS.A reported earnings per ADS (on a current cost of supplies basis, excluding items – the market’s preferred measure) of $1.36, below the Zacks Consensus Estimate of $1.43 but above the year-ago profit of $1.00. Estimate Revision Trend & Surprise History: The stock had seen the Zacks Consensus Estimate for second-quarter earnings being revised 2% upward over the last 30 days. Coming to earnings surprise history, the blue-chip company has a good record: its beaten estimates in three of the last four quarters, as shown in the chart below: Royal Dutch Shell PLC Price and EPS Surprise Royal Dutch Shell PLC Price and EPS Surprise | Royal Dutch Shell PLC Quote Revenues: Revenues of $101.5 billion were 31% above the third-quarter 2017 sales of $77.7 billion […]

Technicals

Moving Average Crossover Alert: Horace Mann Educators (HMN)

Horace Mann Educators Corporation HMN could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for HMN broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness. This has already started to take place, as the stock has moved lower by 11.4% in the past four weeks […]

Technicals

DowDuPont (DWDP) Q3 Earnings Beat, Sales Miss Estimates

DowDuPont Inc. DWDP , which was formed through the merger of Dow Chemical and DuPont, engages in agriculture, materials science, and specialty products businesses globally. Earnings DowDuPont raked in adjusted earnings of 74 cents per share for the third quarter that topped the Zacks Consensus Estimate of 71 cents […]

Technicals

Amarin (AMRN) Beats Earnings & Misses Revenues in Q3

Amarin Corporation PLC AMRN is a pharmaceutical company focused on developing innovating treatments for improving cardiovascular health. The company’s sole marketed drug, Vascepa, is approved as an adjunct to diet to reduce triglyceride levels in severe hypertriglyceridemia patients. Amarin’s earnings track record has been mixed so far […]

Mergers & Acquisitions

Genstar Capital Announces Acquisition of 2-10 Home Buyers Warranty

Genstar Capital Announces Acquisition of 2-10 Home Buyers Warranty Strong Platform Combined with Genstar’s Resources and Insurance Industry Expertise to Drive Meaningful Growth PR Newswire SAN FRANCISCO, Nov. 1, 2018 SAN FRANCISCO , Nov. 1, 2018 /PRNewswire/ — Genstar Capital, a leading private equity firm focused on investments in targeted segments of the financial services, software, industrial technology, and healthcare industries, today announced the acquisition of 2-10 Home Buyers Warranty (2-10 HBW), a provider of home warranty products to homeowners and new home builders […]

Mergers & Acquisitions

Precision BioLogic Acquires Affinity Biologicals

Precision BioLogic Acquires Affinity Biologicals PR Newswire HALIFAX, Nov. 1, 2018 HALIFAX , Nov. 1, 2018 /PRNewswire/ – Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the completed acquisition of Affinity Biologicals Inc., a primary manufacturer of reagents and kits used in hemostasis and thrombosis research and diagnostics. […]

Stock Analysts

Express Scripts (ESRX) Tops Q3 Earnings & Revenue Estimates

Express Scripts Holding Company ESRX posted third-quarter 2018 adjusted earnings of $2.43 per share, which beat the Zacks Consensus Estimate of $2.42. Further, adjusted earnings improved 27.9% year over year. Revenues of $25.56 billion surpassed the Zacks Consensus Estimate of $24.99 billion and inched up 3.6% year over year […]